Status:
COMPLETED
Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders
Lead Sponsor:
Yazd Medical University
Collaborating Sponsors:
Yazd Research & Clinical Center for Infertility
Conditions:
Pregnancy
Eligibility:
FEMALE
38-45 years
Phase:
PHASE4
Brief Summary
Despite the progression in assisted reproductive technology (ART), the preferred protocol for poor responders is still controversial. The management of poor responders consists of 10% of ART cycles . ...
Detailed Description
Despite the progression in assisted reproductive technology (ART) , the preferred protocol for poor responders is still controversial. The management of poor responders consists of 10% of ART cycles ....
Eligibility Criteria
Inclusion
- Women with ≥38 years old
- women who had one or more previous failed IVF cycles in which three or fewer oocyte were been retrieved and/or serum E2 level on the day of hCG administration was ≤500 pg/ml were enrolled in this study
Exclusion
- BMI \> 30
- endocrine disorders
- metabolic disorders
- history of ovarian surgery
- sever endometriosis
- sever male factor ( azospermia )
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT01213147
Start Date
April 1 2009
End Date
May 1 2010
Last Update
October 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yazd Research and Clinical Center for Infertility
Yazd, Yazd Province, Iran, 8916877391